诺和诺德Ozempic获欧盟推荐使用以治疗动脉疾病

格隆汇
24 Jun

诺和诺德周一宣布,欧洲委员会建议使用其2型糖尿病和减肥胖药物Ozempic,用以针对外周动脉疾病(PAD)以及其主要治疗问题。该公司表示,预计欧洲委员会将在约两个月内更新该药物的标签。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10